- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$28.4b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$194.52
7D
-1.9%
1Y
25.8%
BioNTech
Market Cap: US$20.8b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$86.81
7D
-8.5%
1Y
-10.6%
Illumina
Market Cap: US$18.9b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$125.98
7D
4.3%
1Y
43.9%
Sam Chun Dang Pharm
Market Cap: ₩21.8t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩1,115,000.00
7D
42.2%
1Y
510.6%
Regencell Bioscience Holdings
Market Cap: US$12.5b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$24.43
7D
6.3%
1Y
2,083.9%
Elanco Animal Health
Market Cap: US$12.2b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$24.90
7D
-1.1%
1Y
136.9%